4.4 Letter

PYK2/FAK inhibitors reverse hypoxia-induced drug resistance in multiple myeloma

Journal

HAEMATOLOGICA
Volume 104, Issue 7, Pages -

Publisher

FERRATA STORTI FOUNDATION
DOI: 10.3324/haematol.2018.194688

Keywords

-

Categories

Funding

  1. Verastem, Inc.
  2. National Center for Advancing Translational Sciences (NCATS) of the National Institutes of Health (NIH)
  3. National Cancer Institute of the NIH [U54CA199092]

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available